Thrivent Financial For Lutherans lessened its position in Clorox Company (The) (NYSE:CLX) by 88.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,925 shares of the company’s stock after selling 37,910 shares during the quarter. Thrivent Financial For Lutherans’ holdings in Clorox Company (The) were worth $656,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. American Beacon Advisors Inc. bought a new position in Clorox Company (The) in the first quarter valued at $104,000. Parkside Financial Bank & Trust increased its stake in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after acquiring an additional 29 shares during the last quarter. Valley National Advisers Inc. increased its stake in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after acquiring an additional 5 shares during the last quarter. Blue Chip Partners Inc. increased its stake in Clorox Company (The) by 3.9% in the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after acquiring an additional 35 shares during the last quarter. Finally, Zions Bancorporation increased its stake in Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after acquiring an additional 53 shares during the last quarter. 71.33% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the previous year, the firm posted $1.30 EPS. The business’s quarterly revenue was up 2.9% on a year-over-year basis.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be issued a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.57%. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.

A number of research analysts recently commented on the company. Jefferies Group LLC reissued a “hold” rating and issued a $137.00 target price (up previously from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Barclays PLC reissued an “equal weight” rating and issued a $136.00 target price (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. BMO Capital Markets set a $150.00 target price on Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday, August 3rd. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. Clorox Company (The) presently has a consensus rating of “Hold” and an average price target of $127.39.

In other news, COO Dawn C. Willoughby sold 2,158 shares of the business’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP James E. Foster sold 9,861 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares in the company, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 21,242 shares of company stock worth $2,944,449. Insiders own 1.00% of the company’s stock.

WARNING: “Clorox Company (The) (CLX) Shares Sold by Thrivent Financial For Lutherans” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/13/clorox-company-the-clx-shares-sold-by-thrivent-financial-for-lutherans.html.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.